CONGENITAL HYPERINSULINISM
Clinical trials for CONGENITAL HYPERINSULINISM explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HYPERINSULINISM trials appear
Sign up with your email to follow new studies for CONGENITAL HYPERINSULINISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame rare blood sugar disorder in kids and adults
Disease control OngoingThis study tests an investigational drug called RZ358 for people with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. About 56 participants aged 3 months to 45 years who haven't responded well to standard treatments will receive either RZ358 or a…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated May 26, 2026 04:41 UTC
-
Promising drug dasiglucagon tested for Long-Term safety in kids with rare Low-Blood-Sugar condition
Disease control OngoingThis study looks at the long-term safety of dasiglucagon, a drug given as a continuous shot under the skin, in children with congenital hyperinsulinism (CHI), a rare condition that causes dangerously low blood sugar. The trial includes 42 children who already completed a previous…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New weekly shot shows promise for rare Low-Blood-Sugar condition
Disease control OngoingThis study tests a new medicine called HM15136 for people aged 2 and older with congenital hyperinsulinism (CHI), a rare condition that causes dangerously low blood sugar. The medicine is given as a weekly shot alongside standard treatments. The goal is to see if it is safe and h…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 22, 2026 14:03 UTC